Back
Supernus Pharmaceuticals Stock Price Chart
Apple's Drop in iPhone Sales Opens the Door for New Entrant
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
40
SUPN
Supernus Pharmaceuticals
Last Price:
$32.74
Seasonality Move:
13.42%
7 Day Trial
ALL ACCESS PASS
$
7
The Tariff-Proof Asset in Your Pocket
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.-
The current trend is relatively stagnant and SUPN is experiencing slight buying pressure.
Supernus Pharmaceuticals Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 32.44 | Buy |
| 20-day SMA: | 32.21 | Buy |
| 50-day SMA: | 34.78 | Sell |
| 200-day SMA: | 33.5 | Sell |
| 8-day EMA: | 32.49 | Buy |
| 20-day EMA: | 32.64 | Buy |
| 50-day EMA: | 33.86 | Sell |
| 200-day EMA: | 33.74 | Sell |
Supernus Pharmaceuticals Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.43 | Sell |
| Relative Strength Index (14 RSI): | 49.06 | Sell |
| Chaikin Money Flow: | 547543 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (31.65 - 32.61) | Buy |
| Bollinger Bands (100): | (33.19 - 38.31) | Sell |
Supernus Pharmaceuticals Technical Analysis
| Mar 24 | Mar 25 | Mar 26 | Mar 27 | Mar 28 | Mar 31 | Apr 1 | Apr 2 | Apr 3 | Apr 4 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar | Apr | |||||||||
| 24 | 25 | 26 | 27 | 28 | 31 | 01 | 02 | 03 | 04 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Supernus Pharmaceuticals Stock
Is Supernus Pharmaceuticals Stock a Buy?
-
Supernus Pharmaceuticals share price is 32.74 while SUPN 8-day simple moving average is 32.44, which is a Buy signal.
-
The stock price of SUPN is 32.74 while Supernus Pharmaceuticals 20-day SMA is 32.21, which makes it a Buy.
-
Supernus Pharmaceuticals 50-day simple moving average is 34.78 while SUPN share price is 32.74, making it a Sell technically.
-
SUPN stock price is 32.74 and Supernus Pharmaceuticals 200-day simple moving average is 33.50, creating a Sell signal.
SUPN Technical Analysis vs Fundamental Analysis
Sell
40
Supernus Pharmaceuticals (SUPN)
is a Sell
Is Supernus Pharmaceuticals a Buy or a Sell?
-
Supernus Pharmaceuticals stock is rated a SellThe current Supernus Pharmaceuticals [SUPN] share price is $32.74. The Score for SUPN is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.
Supernus Pharmaceuticals Stock Info
Market Cap:
1.8B
Price in USD:
32.74
Share Volume:
1.5M
Supernus Pharmaceuticals 52-Week Range
52-Week High:
40.28
52-Week Low:
25.53
Sell
40
Supernus Pharmaceuticals (SUPN)
is a Sell
Supernus Pharmaceuticals Share Price Forecast
-
What is the Supernus Pharmaceuticals stock price today?The Supernus Pharmaceuticals stock price is 32.74 USD today.
-
Will SUPN stock go up or go down?Supernus Pharmaceuticals> share price is forecast to RISE/FALL based on technical indicators
-
Is Supernus Pharmaceuticals overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Supernus Pharmaceuticals is overvalued.
Is Supernus Pharmaceuticals Stock a Buy?
-
Supernus Pharmaceuticals share price is 32.74 while SUPN 8-day exponential moving average is 32.49, which is a Buy signal.
-
The stock price of SUPN is 32.74 while Supernus Pharmaceuticals 20-day EMA is 32.64, which makes it a Buy.
-
Supernus Pharmaceuticals 50-day exponential moving average is 33.86 while SUPN share price is 32.74, making it a Sell technically.
-
SUPN stock price is 32.74 and Supernus Pharmaceuticals 200-day simple moving average is 33.74, creating a Sell signal.
Fundamental Analysis of Supernus Pharmaceuticals
Is Supernus Pharmaceuticals a good investment?
-
Analysts estimate an earnings decrease this quarter of $0.10 per share, a decrease next quarter of $0.09 per share, a decrease this year of $0.91 per share, and an increase next year of $0.58 per share.
Technical Analysis of Supernus Pharmaceuticals
Should I short Supernus Pharmaceuticals stock?
-
SUPN Moving Average Covergence Divergence (MACD) indicator is -0.43, suggesting Supernus Pharmaceuticals is a Sell
-
Supernus Pharmaceuticals Relative Strength Index (RSI) is 49.06, which suggest Supernus Pharmaceuticals is oversold
-
The Bollinger Bands (25) for Supernus Pharmaceuticals is (31.65 - 32.61), which suggest Supernus Pharmaceuticals is a Sell
-
The Bollinger Bands (100) for Supernus Pharmaceuticals is (33.19 - 38.31), which suggest Supernus Pharmaceuticals is a Sell
* Supernus Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.